Etherington Robert Dee 4

What Happened Robert D. Etherington, President & CEO and a director of Clene Inc., received a grant of options to acquire 75,000 shares of Clene common stock on January 22, 2026. The Form 4 reports the award as a derivative acquisition (code A) with an acquisition amount of $0; the options carry an exercise price of $5.42 per share and vest immediately upon grant.

Key Details

• Transaction date: January 22, 2026; Form 4 filed January 23, 2026 (timely filing).
• Grant: 75,000 stock options under the Clene Inc. Amended 2020 Stock Plan.
• Exercise price: $5.42 per share; options vested immediately per the footnote.
• Amount paid at grant: $0 (derivative award — no cash paid to acquire the options at grant).
• Post-transaction total shares/options held: not specified in the supplied excerpt.
• Footnote: F1 states the options were granted under the Amended 2020 Stock Plan and vest immediately.
• No 10b5-1 plan, tax-withholding, or cashless exercise noted in the provided information.

Context This transaction is a grant of stock options (a derivative award), not an immediate purchase of shares. Because the options vested immediately, Etherington can exercise them moving forward by paying the $5.42 per-share exercise price to receive common shares; the filing does not show any exercise or sale. Grants like this are commonly used for executive compensation and retention; they do not on their own indicate a market transaction (buy or sell) until exercised or sold.